Junya Fukuoka Selected Research

Lymphatic Metastasis

1/2017	Synaptonemal complex protein 3 is associated with lymphangiogenesis in non-small cell lung cancer patients with lymph node metastasis.
4/2013	Synaptonemal complex protein 3 as a novel prognostic marker in early stage non-small cell lung cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Junya Fukuoka Research Topics

Disease

53	Neoplasms (Cancer) 01/2022 - 10/2004
18	Lung Neoplasms (Lung Cancer) 01/2021 - 10/2004
16	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2021 - 03/2005
12	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2020 - 07/2005
11	Adenocarcinoma 11/2021 - 02/2007
10	Adenocarcinoma of Lung 11/2021 - 07/2004
10	Carcinoma (Carcinomatosis) 01/2021 - 10/2004
8	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2018 - 07/2004
6	Neoplasm Metastasis (Metastasis) 11/2020 - 02/2011
6	Carcinogenesis 01/2019 - 01/2006
5	Stomach Neoplasms (Stomach Cancer) 08/2021 - 07/2011
5	Idiopathic Pulmonary Fibrosis 01/2021 - 07/2005
4	Bronchiectasis 07/2022 - 01/2013
4	Dyspnea (Shortness of Breath) 01/2020 - 01/2013
4	Disease Progression 05/2019 - 12/2010
4	Connective Tissue Diseases (Connective Tissue Disease) 11/2018 - 01/2013
4	Neuroendocrine Tumors (Neuroendocrine Tumor) 12/2015 - 10/2004
3	Fibrosis (Cirrhosis) 01/2022 - 12/2011
3	Hyperplasia 01/2021 - 01/2012
3	Breast Neoplasms (Breast Cancer) 08/2018 - 07/2009
3	Esophageal Squamous Cell Carcinoma 01/2017 - 12/2012
2	Extrinsic Allergic Alveolitis (Hypersensitivity Pneumonitis) 07/2022 - 07/2005
2	Thymoma (Thymic Carcinoma) 03/2022 - 01/2020
2	Lymphoma (Lymphomas) 12/2021 - 01/2015
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 11/2021 - 12/2010
2	Necrosis 11/2021 - 01/2010
2	Infections 02/2021 - 01/2020
2	Human Influenza (Influenza) 02/2021 - 01/2020
2	Pneumonia (Pneumonitis) 01/2020 - 01/2019
2	Vascular Diseases (Vascular Disease) 01/2020 - 07/2005
2	Cysts 01/2019 - 09/2010
2	Metaplasia 01/2018 - 07/2005
2	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2018 - 01/2016
2	Vasculitis (Vasculitides) 01/2018 - 12/2012
2	Prostatic Neoplasms (Prostate Cancer) 10/2017 - 01/2014
2	Urinary Bladder Neoplasms (Bladder Cancer) 09/2017 - 01/2017
2	Lymphatic Metastasis 01/2017 - 04/2013
2	Dermatomyositis (Dermatopolymyositis) 01/2016 - 03/2014
2	Respiratory Insufficiency (Respiratory Failure) 01/2016 - 12/2010
2	Melanoma (Melanoma, Malignant) 01/2016 - 04/2013
2	Hypertension (High Blood Pressure) 12/2015 - 01/2012
2	Spontaneous Remission 01/2015 - 12/2010
2	Colorectal Neoplasms (Colorectal Cancer) 06/2014 - 07/2012

Drug/Important Bio-Agent (IBA)

15	Proteins (Proteins, Gene)FDA Link 01/2022 - 07/2004
8	Biomarkers (Surrogate Marker)IBA 11/2021 - 10/2004
5	Cisplatin (Platino)FDA LinkGeneric 08/2021 - 01/2012
5	Phosphotransferases (Kinase)IBA 02/2021 - 03/2005
5	Pharmaceutical PreparationsIBA 11/2019 - 01/2012
5	LigandsIBA 05/2019 - 12/2016
4	RNA (Ribonucleic Acid)IBA 10/2021 - 10/2004
4	Biological ProductsIBA 10/2021 - 10/2010
4	Formaldehyde (Formol)FDA Link 04/2021 - 07/2011
4	pembrolizumabIBA 01/2021 - 12/2018
4	Indicators and Reagents (Reagents)IBA 01/2019 - 06/2013
3	Adrenal Cortex Hormones (Corticosteroids)IBA 05/2022 - 11/2018
3	AcidsIBA 03/2022 - 06/2015
3	ParaffinIBA 04/2021 - 07/2011
3	CarcinogensIBA 01/2021 - 10/2017
3	CollagenIBA 01/2020 - 07/2005
3	AntibodiesIBA 05/2019 - 12/2010
3	Tacrolimus (Prograf)FDA LinkGeneric 01/2019 - 01/2013
3	NivolumabIBA 12/2018 - 12/2017
3	AntigensIBA 01/2017 - 06/2012
3	ErbB Receptors (EGF Receptor)IBA 08/2013 - 03/2005
2	HABAIBA 07/2022 - 02/2013
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 03/2022 - 01/2014
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 12/2021 - 11/2021
2	Adenosine Triphosphatases (ATPase)IBA 05/2021 - 07/2010
2	CytokinesIBA 01/2021 - 01/2017
2	Messenger RNA (mRNA)IBA 01/2021 - 12/2013
2	PlatinumIBA 01/2021 - 05/2019
2	S-1 plus cisplatinIBA 01/2020 - 01/2012
2	Immune Checkpoint InhibitorsIBA 05/2019 - 01/2017
2	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 09/2009
2	FibrinIBA 01/2018 - 08/2003
2	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2018 - 12/2012
2	Peroxidase (Myeloperoxidase)IBA 01/2018 - 12/2012
2	AutoantibodiesIBA 01/2018 - 12/2015
2	Phenobarbital (Luminal)FDA Link 09/2017 - 04/2008
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017 - 01/2017
2	Tumor Suppressor Protein p14ARF (p14ARF)IBA 01/2017 - 08/2013
2	MicroRNAs (MicroRNA)IBA 02/2014 - 07/2011
2	Keratin-5 (Keratin 5)IBA 09/2013 - 02/2012
2	Desmoglein 3IBA 09/2013 - 02/2007
2	Tyrosine Kinase InhibitorsIBA 08/2013 - 03/2005
2	Gefitinib (Iressa)FDA Link 08/2013 - 01/2011
2	Gemcitabine FDA Link 07/2013 - 02/2011
2	Fluorouracil (Carac)FDA LinkGeneric 07/2012 - 05/2011
2	Thyroid Nuclear Factor 1IBA 02/2012 - 02/2012
2	VimentinIBA 01/2010 - 02/2009

Therapy/Procedure

22	Therapeutics 05/2022 - 03/2005
14	Drug Therapy (Chemotherapy) 08/2021 - 04/2007
4	Traction 07/2022 - 01/2013
3	Radiotherapy 01/2020 - 04/2007
2	Immunotherapy 11/2021 - 11/2019
2	Hysterectomy 10/2021 - 09/2010
2	Artificial Respiration (Mechanical Ventilation) 09/2019 - 12/2010
2	Hematopoietic Stem Cell Transplantation 01/2019 - 01/2019
2	Prostatectomy (Retropubic Prostatectomy) 10/2017 - 01/2014
2	Lasers (Laser) 06/2015 - 10/2004